Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension: Results of the treatment of mild hypertension study

Archives of Internal Medicine

Volumn 156, Issue 4, 1996, Pages 377-385

  Lewis, Cora E ^a,f   Grandits, Greg A ^b   Flack, John ^d   McDonald, Robert ^e   Elmer, Patricia J ^c  

^a Center for Palliative Care   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMLODIPINE BESYLATE; CHLORTALIDONE; DOXAZOSIN MESYLATE; ENALAPRIL MALEATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG TOLERANCE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0030060087     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.4.377     Document Type: Article

References (42)

1. Medical Research Council Working Party. MRC trial of mild hypertension principal results. BMJ. 1985,291:97-104
2. Bulpitt CJ, Beevers DG, Butler A, et al. Treated blood pressure, rather than pretreatment, predicts survival in hypertensive patients, a report from the DHSS Hypertension Care Computing Project (DHCCP) J Hypertens. 1988;6:627-632.
3. Report by the Management Committee. The Australian therapeutic trial in mild hypertension. Lancet. 1980;1:1261-1267.
4. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;1:1349-1354.
5. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, II: mortality by race-sex and age JAMA 1979,242:2572-2577
6. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
7. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265.3255-3264
8. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results BMJ 1992,304.405-412.
9. Anastos K, Charney P, Charon RA, et al Hypertension in women: what is really known? the women's caucus, working group on women's health of the Society of General Internal Medicine. Ann Intern Med. 1991;115:287-293.
10. Browner WS, Hulley SB. Effect of risk status on treatment criteria: implications of hypertension trials. Hypertension. 1989,13(suppl) I-51-I-56.
11. Jackson R, Barham P, Bills J, et al. Management of raised blood pressure in New Zealand: a discussion document BMJ. 1993,307 107-110
12. MacMahon S, Cutler JA, Stamler J Antihypertensive drug treatment: potential, expected, and observed effects on stroke and on coronary heart disease Hypertension 1989; suppl I-45-I-50.
13. Bradley K, Flack JM, Belcher J, Elmer P, Miller P, Grimm R Jr. Chlorthalidone attenuates the reduction in total cholesterol and small dense LDL-cholesterol subclass associated with weight loss Am J Hypertens 1993;6:636-639.
14. Lardinois CK, Neuman S The effects of antihypertensive agents on serum lipids and lipoproteins. Arch Intern Med. 1988;148:1280-1288.
15. Grimm RH Jr, Leon AS, Humminghake DB, Lenz K, Hannan P, Blackburn H Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med. 1981,94:7-11.
16. Lasser NL, Grandits G, Caggiula AW, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial Am J Med. 1984;76:52-66
17. Boehringer K, Weidmann P, Mordasini R, et al. Menopause-dependent plasma lipoprotein alterations in diuretic-treated women Ann Intern Med. 1982;97:206-209.
18. Stamler J, Prineas RJ, Neaton JD, et al. Background and design of the new U.S. trial on diet and drug treatment of 'mild' hypertension (TOMHS). Am J Cardiol. 1987;59(suppl):51G-60G.
19. Mascioli S, Grimm RH, Neaton JD, et al. The Treatment of Mild Hypertension Study (TOMHS): characteristics of participants at baseline. Am J Cardiol. 1990; 66:32C-35C.
20. The Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study: a randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med. 1991;151:1413-1423.
21. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study (TOMHS): final results. JAMA. 1993;270:713-724.
22. Curb JD, Labarthe DR, Cooper SP, Cutter GR, Hawkins CM. Training and certification of BP observers. Hypertension 1983,5:610-614.
23. Dischinger P, DuChene AG Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial Control Clin Trials 1986,7(Suppl) 137S-157S.
24. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA 1989;262:925-930.
25. Rautaharju PM, MacInnis PJ, Warren JW, et al. Methodology of ECG interpretation in the Dalhousie Program: Novacode ECG classification procedures for clinical trials and population health studies. Methods Inf Med 1990,29:362-374
26. Prineas RJ, Crow R, Blackburn H The Minnesota Code Manual of Electrocardiographic Findings. Littleton, Mass: John Wright-PSG Inc, 1982:1-229.
27. Lipid Research Clinics Program Manual of Operations, I. Lipid and Lipoprotein Analysis. Bethesda, Md: US Dept of Health, Education, and Welfare, National Institutes of Health 1974 US Dept of Health, Education, and Welfare publication 75-628.
28. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preoperative ultracentrifuge. Clin Chem 1972,18 499-502.
29. Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
30. Laird NM, Ware JM. Random-effects models for longitudinal data Biometrics. 1984;31:511-529
31. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR Menopause and risk factors for coronary heart disease N Engl J Med 1989,321:641-646.
32. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL Weight gain at the time of menopause. Arch Intern Med. 1991;151:97-102.
33. Kramer FM, Jeffrey RW, Forster JL, Snell MK Long-term follow-up of behavioral treatment for obesity, patterns of weight regain among men and women. Int J Obes Relat Metab Disord 1989;13:123-136.
34. O'Neil PM, Currey HS, Hirsch AA, et al. Effects of sex of subject and spouse involvement on weight loss in a behavioral treatment program: a retrospective investigation Addict Behav. 1979,4 167-177
35. Foreyt JP, Mitchell RE, Garner DT, Gee M, Scott LW, Gotto AM. Behavioral treatment of obesity: results and limitations. Behav Ther. 1982,13:153-161.
36. Fu YS, Gambone JC, Berek JS. Pathophysiology and management of endometrial hyperplasia and carcinoma West J Med. 1990,153:50-61.
37. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
38. M'Buyamba-Kabangu JR, Lepira B, Fagard R, et al. Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients. Eur J Clin Pharmacol. 1986;29:523-527.
39. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990,150:1707-1713.
40. Cubeddu LX, Aranda J, Singh B, et al. A comparison of verapamil and propranolol for the initial treatment of hypertension: racial differences in response JAMA. 1986,256.2214-2221
41. Hypertension Detection and Follow-up Program Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertensive Detection and Follow-up Program JAMA. 1988;259 2113-2122.
42. Amery A, Birkenhager W, Brixko P, et al Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years: EWPHE results: sub-group analysis based on entry stratification J Hypertens. 1986; 4(suppl 6) S642-S647.